MYnd Analytics Announces a Strategic One Million Dollar Equity Investment
Mar 21, 2017 12:31 pm UTC| Business
NEW YORK, March 21, 2017 -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce trial and error treatment in mental...
Onconova Therapeutics, Inc. to Present at Two Upcoming Healthcare Conferences
Mar 21, 2017 12:30 pm UTC| Business
NEWTOWN, Pa., March 21, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Mar 21, 2017 12:30 pm UTC| Business
LEIDEN, Netherlands and CHIPPENHAM, United Kingdom, March 21, 2017 -- IXYS Corporation (NASDAQ:IXYS) an international power and IC semiconductor company, today announced that its wholly owned UK subsidiary, IXYS UK...
Mar 21, 2017 12:30 pm UTC| Business
NORCROSS, Ga., March 21, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will release fourth quarter and full year...
Mar 21, 2017 12:30 pm UTC| Business
VANCOUVER, B.C., March 21, 2017 -- Skyharbour Resources Ltd.(TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”), is pleased to announce it will be expanding its current diamond drill program at its flagship Moore...
Mar 21, 2017 12:30 pm UTC| Business
MADISON, Wis., March 21, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today announces the United States Patent and Trademark Office has...
Mar 21, 2017 12:30 pm UTC| Business
SOLANA BEACH, Calif., March 21, 2017 -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company’s abstract...